BRK-B vs ETB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
ETB presents a classic value trap profile: fundamentally undervalued with a stable Piotroski F-Score of 5/9, yet plagued by severe technical weakness (10/100). While the Graham Number ($27.41) and Intrinsic Value ($60.18) suggest massive upside from the current price of $15.15, the negative revenue growth and bearish insider sentiment offset these metrics. The fund remains an attractive income vehicle due to its 8.38% yield, but the lack of price momentum suggests a period of stagnation or further decline before value is realized.
Compare Another Pair
Related Comparisons
BRK-B vs ETB: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Eaton Vance Tax-Managed Buy-Write Income Fund (ETB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.